The new financial support comes shortly after Scipher closed its Series B funding round, which brought its total amount raised to $30 million. Optum Ventures’ equity investment marks a second close of the Series B round, and will be used to accelerate and expand Scipher’s technology to treat more diseases, per a Feb. 19 news release.
Scipher’s platform uses artificial intelligence and molecular diagnostic technology to recommend to physicians the most effective treatment based on a patient’s individual biology. The platform is currently focused on treating autoimmune conditions.
More articles on health IT:
WHO joins TikTok to battle coronavirus misinformation
Walgreens warns mobile app users that personal data may have been leaked
Hawaii health system notifies 2,900 patients of email mix-up
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
